GOVX GOVX
Company Profile ↓Company Overview
GOVX (GOVX) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 13.0% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $2.49M (-37.1% YoY); net profit $-21.46M.
- Trailing 12 Months Year-on-year growth — revenue -37.1%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.0%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.00% |
| 1 Year: | -37.06% |
Stock Price Performance
| 1 Year: | -96.18% |
| 6 Months: | -71.79% |
| 3 Months: | -47.76% |
| 1 Month: | -37.66% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)34.68 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.0% over 5 years.
CONS
- Trading 96.2% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | 295.74K | 352.14K | 247.99K | 221.30K | 93.27K | 349.34K | 364.23K | 209.94K | 333.21K | 715.98K | 440.60K | 415.46K | 110.42K | 79.71K | 30.41K | 81.53K | 0 | 0 | 0 | 0 | 0 | 0 | 300.68K | 2.79M | 1.64M | 852.28K | 0 | 0 | 0 |
| Operating Income | -617.32K | -680.62K | -515.23K | - | -701.65K | -678.07K | -621.32K | - | -1.30M | -576.11K | -464.54K | -548.73K | -518.15K | -590.35K | -622.92K | -638.13K | -667.33K | -701.55K | -653.94K | -425.94K | -595.30K | -448.11K | -436.31K | -1.56M | -1.49M | -1.95M | -2.43M | -2.24M | -3.97M | -4.27M | -6.18M | -8.60M | -5.88M | -5.06M | -5.85M | -5.41M | -5.42M | -6.37M | -5.27M | -4.44M |
| Net Income | -615.92K | -679.54K | -514.51K | -923.59K | -700.45K | -676.20K | -619.90K | -692.73K | -1.30M | -575.84K | -464.20K | -548.34K | -516.88K | -588.76K | -621.81K | -637.04K | -666.89K | -701.45K | -654.15K | -424.43K | -595.69K | -455.20K | -570.65K | -1.56M | -1.31M | -1.95M | -2.43M | -2.24M | -3.97M | -4.04M | -5.93M | -8.41M | -5.85M | -5.06M | -5.82M | -5.36M | -5.37M | -6.32M | -5.26M | -4.43M |
| R&D Expense | 402.86K | 516.20K | 425.50K | - | 403.63K | 384.65K | 378.52K | - | 438.00K | 397.58K | 683.94K | 551.79K | 518.10K | 498.20K | 486.99K | 372.20K | 557.70K | 555.72K | 451.23K | 467.67K | 808.94K | 461.42K | 416.76K | 602.78K | 832.84K | 1.22M | 1.33M | 1.31M | 2.72M | 2.82M | 4.72M | 6.95M | 4.43M | 4.28M | 7.40M | 5.35M | 4.73M | 5.04M | 3.90M | 3.11M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2002 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 828.92K | 1.08M | 963.20K | 1.18M | 1.82M | 385.50K | 81.53K | 0 | 3.95M | 2.49M |
| Operating Income | - | - | - | - | - | - | - | -3.32M | -2.77M | -2.35M | -2.14M | -2.29M | -2.74M | -2.69M | -3.27M | -2.17M | -2.56M | -2.37M | -2.82M | -18.75M | -14.03M | -26.74M | -25.14M | -21.64M |
| Net Income | -618.14K | -947.80K | -2.35M | -1.61M | -584.17K | -4.24M | -3.73M | -3.28M | -2.75M | -2.35M | -2.14M | -2.28M | -2.73M | -2.69M | -3.27M | -2.17M | -2.56M | -2.37M | -2.96M | -18.57M | -14.02M | -25.97M | -24.99M | -21.46M |
| R&D Expense | - | - | - | - | - | - | - | 4.07M | 4.79M | 4.28M | 3.04M | 2.91M | 1.81M | 1.69M | 1.97M | 2.02M | 1.88M | 1.91M | 2.44M | 15.55M | 9.12M | 20.72M | 23.71M | 18.12M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2001 | Dec 2002 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | - | - | - | - | - | - | - | 2.36M | 1.65M | 1.48M | 2.84M | 1.33M | 1.33M | 610.22K | 490.24K | 642.06K | 468.88K | 10.39M | 11.80M | 31.35M | 9.28M | 8.16M | 6.34M |
| Total Equity | -170.58K | -639.39K | 872.41K | -389.50K | -500.58K | 2.20M | 2.65M | 2.71M | 3.74M | 1.84M | 703.61K | 1.15M | 2.53M | 1.15M | 1.20M | 240.37K | -321.06K | -1.02M | -1.57M | 9.57M | 4.36M | 26.60M | 5.76M | 5.05M | 3.83M |
| Cash & Equivalents | - | - | - | - | - | - | - | 2.19M | 3.52M | 1.08M | 1.17M | 1.04M | 2.51M | 1.10M | 1.06M | 454.03K | 312.73K | 259.70K | 283.34K | 9.88M | 11.42M | 27.61M | 6.45M | 5.51M | 3.09M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 811.29K | 1.66M | 2.04M | 825.05K | 7.44M | 4.75M | - | 3.11M | 2.52M |
| Current Liabilities | - | - | - | - | - | - | - | - | - | 521.61K | 941.53K | 327.04K | 312.35K | 187.02K | 126.99K | 369.85K | 811.29K | 1.62M | 2.02M | 810.31K | 5.44M | 4.75M | 3.52M | 3.11M | 1.94M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.43M | -2.44M | -303.62K | -2.44M | -1.69M | -2.25M | -2.71M | -1.95M | -1.69M | -1.54M | -1.40M | -2.75M | -11.20M | -19.03M | -25.17M | -24.68M | -21.47M |
| Investing Cash Flow | -270.25K | 874 | -11.90K | - | -86.60K | -35.50K | -15.85K | - | -4.35K | - | -7.61K | -156.79K | -47.72K | -134.26K | -48.95K | -20.65K | -27.61K |
| Financing Cash Flow | 3.02M | -430.40K | 404.41K | 2.31M | 3.26M | 873.40K | 2.68M | 1.34M | 1.55M | 1.49M | 1.43M | 12.51M | 12.78M | 35.35M | 4.06M | 23.75M | 19.08M |
| Capital Expenditure | -270.25K | -4.71K | -11.90K | - | -86.60K | -35.50K | -15.85K | - | -4.35K | - | -7.61K | -156.79K | -47.72K | -134.26K | -48.95K | -20.65K | -27.61K |
| Free Cash Flow | -1.70M | -2.44M | -315.52K | - | -1.78M | -2.29M | -2.72M | - | -1.69M | - | -1.41M | -2.91M | -11.24M | -19.16M | -25.22M | -24.70M | -21.50M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2002 | Dec 2003 | Dec 2004 | Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -394.9% | -202.2% | -266.1% | -201.8% | -154.5% | -4,862.7% | -17,207.5% | - | -635.8% | -869.3% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -394.7% | -201.8% | -265.8% | -201.6% | -162.2% | -4,817.2% | -17,198.3% | - | -632.0% | -862.3% |
| ROE % | 96.7% | -108.6% | 603.8% | 321.8% | -26.5% | -160.2% | -137.6% | -87.7% | -149.6% | -333.5% | -185.5% | -90.4% | -238.5% | -223.3% | -1,361.1% | 675.9% | 250.4% | 150.6% | -30.9% | -425.8% | -52.7% | -450.6% | -495.0% | -561.2% |
| ROCE % | - | - | - | - | - | - | - | - | -150.9% | -333.9% | -185.8% | -90.6% | -238.8% | -223.7% | -1,361.8% | 677.3% | 260.8% | 153.3% | -29.4% | -294.7% | -52.7% | -464.0% | -498.1% | -491.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for GOVX
Why Is GOVX Stock Falling Today? - Stocktwits
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxNSzFnVkYxUjluT2NtTTByMjJNeVpRTkFjek5jRnNlekh3OTAyLVhaQ2pfY2lfWnVOa0kxYkRpNk1ZNGVPRTFsWEFlSHI4bTFhWGs3S2hJb016X244QmNKdjMyWWRvbDdaTXNRRDd4X2VaT1NOZlM2UDRhUHl1alMxZWw3bF83ZjBBb2FMU0…
GeoVax Labs (GOVX) Stock Fair Value Moves Lower After Pipeline Shift - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPTXpxN1dVUFpHS1loSC1HNGxLbERVV1l5QVR5UU5xa0dYQUhaVUNzanZQcE1ia1haMzFER2JNR0w0Q25nTDRsaFR6WHBvY0Vwb0g5d3UwNmJqMFgzUHVSZ0o3WTI1cmc0T3FDR041SDlvN3FfbTRrd0I4Tm9CNkYwc3VWZ0gtSFk3R3J0VG…
GOVX Stock Became A Hot Biodefense Trade Amid Ebola, Hantavirus Concerns - Stocktwits
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQX0xRaDZkMXJSaElmbmxzMGZhbGkzN2NOWHVnWUh3SUtjSDBHeGhSU0R2Wk1QMzBNUXdCc1BoRUhSZHRrUUs4UG9xdEllRVhOR01mVTR6NFJvR1pINlVQQk5nWm4zR0tYSk9DaDdXVGV5ekktSEQwT0NHc3NFQVFLSDhNR25GdnJzcEtRV2…
GEOVAX LABS ($GOVX) Releases Q2 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMijAFBVV95cUxPM0R0enNNcGk1WFlSdUdyamh2T1RHQzhLWHJudG5RdlFWS0x5bUFvWVJINm1rS0t5dHR2ZXR1S3J0eS1ieW84b1h1WUx0OUZ1dVY0R2d0OGFDdkROUWcwUzlZRXRrTjhvUWdjUzZOeVN2aVBBdDdLcTdkX1hRY2xST0N3V1JQS2w5bzdrSA…
GeoVax Labs Inc (NASDAQ: GOVX) Share Price, GOVX Stock News, GOVX Share Price & Updates - Kalkine
<a href="https://news.google.com/rss/articles/CBMiVkFVX3lxTE1uV0lwUlJmZHpLZTNwWm4yUjJiQnVxYUhhRy1oSFRyNG5NRUNPY1NpMlVwemNWSG1HQVhnWnAxV2R0dmYxNjU1MVJlSkFXdWNLSU1iWjNR?oc=5" target="_blank">GeoVax Labs Inc (NASDAQ: GOVX) Share Price, GOVX St…
GeoVax Labs (GOVX) narrows loss but warns on cash runway and Nasdaq risk - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOTWw2Um13NlM1c0NValEtSldnbXVTcmc0U2NxcE9JV2Q1SWxKV0hxT0lMS05PdUFfZ195M3dpVlpZV3ZOR29zOUxGdGVGNVpMWnY2ai1YdTZoeTBtZG5IcHJ2bU1qS2JKbDI0d1hJQ0NRMmdVVFpVWFNyWGppWXFKME1yTlJ2eUpSV0E4U0…
GOVX — Frequently Asked Questions
What is the current share price of GOVX?
As of 2026-08-05 17:25 PDT, GOVX trades at $0.74 on NASDAQ/NYSE. Its 52-week range is $0.68 to $19.58.
Is GOVX a good stock to buy?
This page provides a data-driven analysis of GOVX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.